India’s small and medium-sized pharma manufacturers are set to face tighter regulatory scrutiny, with the Central Drugs Standard Control Organisation (CDSCO) directing state authorities to conduct inspections under the revised Schedule M manufacturing norms. The move marks the end...
Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd. Hyderabad, have been given the regulatory approval by DCGI to undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the drug Colchicine...
Dr. Harsh Vardhan, Union Health & Family Welfare Minister launched the ‘AYUSH Sanjivani’ App and two AYUSH based studies related to COVID-19 situation, here today, in the presence of Shri Shripad Yesso Naik, MoS (I/c), AYUSH who participated through...
